Weiss Ratings Reiterates Sell (D) Rating for Aspen Aerogels (NYSE:ASPN)

Key Points

• Weiss Ratings has reiterated a "sell (d)" rating for Aspen Aerogels (NYSE:ASPN), amid mixed analyst sentiments with one strong buy and four buy ratings issued recently.
• Aspen Aerogels reported a quarterly earnings per share of (0.04), exceeding expectations, but its revenue reflected a 33.8% year-over-year decline.
• Hedge fund activity around Aspen Aerogels has increased, with multiple firms adjusting their holdings, indicating a growing institutional interest in the stock.

Aspen Aerogels (NYSE:ASPN - Get Free Report)'s stock had its "sell (d)" rating reiterated by Weiss Ratings in a report released on Friday,Weiss Ratings reports.

Other equities analysts also recently issued reports about the stock. Barclays downgraded shares of Aspen Aerogels from an "equal weight" rating to an "underweight" rating and upped their price objective for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Canaccord Genuity Group lowered their price objective on shares of Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a research note on Friday, August 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $15.50.

Aspen Aerogels Trading Up 4.0%

Aspen Aerogels stock traded up $0.32 during mid-day trading on Friday, hitting $8.47. The company's stock had a trading volume of 1,326,621 shares, compared to its average volume of 1,970,775. The company has a debt-to-equity ratio of 0.34, a current ratio of 3.98 and a quick ratio of 3.31. The stock has a market cap of $697.92 million, a price-to-earnings ratio of -2.22 and a beta of 2.80. The business has a 50 day moving average price of $7.26 and a 200-day moving average price of $6.60. Aspen Aerogels has a 12 month low of $4.16 and a 12 month high of $20.19.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.08. The business had revenue of $78.02 million during the quarter, compared to the consensus estimate of $72.53 million. Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The firm's revenue for the quarter was down 33.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.21 earnings per share. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

Insider Activity

In related news, CAO Santhosh P. Daniel sold 4,410 shares of the business's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.31, for a total transaction of $32,237.10. Following the transaction, the chief accounting officer owned 19,879 shares in the company, valued at $145,315.49. The trade was a 18.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.30% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Aspen Aerogels

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Perigon Wealth Management LLC increased its position in shares of Aspen Aerogels by 30.3% during the third quarter. Perigon Wealth Management LLC now owns 49,321 shares of the construction company's stock valued at $343,000 after buying an additional 11,455 shares during the period. Inspire Investing LLC purchased a new position in shares of Aspen Aerogels during the third quarter valued at about $460,000. ARS Investment Partners LLC increased its position in shares of Aspen Aerogels by 6.2% during the third quarter. ARS Investment Partners LLC now owns 60,007 shares of the construction company's stock valued at $418,000 after buying an additional 3,500 shares during the period. Harbour Capital Advisors LLC purchased a new stake in Aspen Aerogels in the third quarter worth about $408,000. Finally, Osaic Holdings Inc. increased its stake in shares of Aspen Aerogels by 29.1% during the second quarter. Osaic Holdings Inc. now owns 10,615 shares of the construction company's stock valued at $63,000 after purchasing an additional 2,390 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.